BD To Invest $1.2-Bn in Pre-Fillable Syringe MfgBy
Becton, Dickinson and Company (BD), a Franklin Lakes, New Jersey-based medical technology company, has announced plans to invest approximately $1.2 billion to expand and upgrade manufacturing capacity and technology for pre-fillable syringes and drug-delivery systems.
The investment, which will be made over a four-year period, will be issued across its six global manufacturing locations and will be used to add a new manufacturing facility in Europe, which is expected to be operational by the end of 2023. The investment will fund capacity expansion, new product innovations, manufacturing technology enhancements and business-continuity improvements across its existing network.
The six current manufacturing facilities for BD Pharmaceutical Systems that will see a portion of this investment include facilities in the following locations: Columbus, Nebraska; Cuautitlán, Mexico; Fukushima, Japan; Le Pont-de-Claix, France; Swindon, UK; and Tatabánya, Hungary.
Source: Becton, Dickinson and Company